Influence of acetaminophen at therapeutic doses on surrogate markers of severity of acute viral hepatitis

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 5, 2006, Pages 763-768

  Yaghi, César ^a   Honein, Khalil ^a   Boujaoude, Joseph ^a   Slim, Rita ^a   Moucari, Rami ^a   Sayegh, Raymond ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL; PROTHROMBIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERBILIRUBINEMIA; MALE; PARAMETER; PROSPECTIVE STUDY; QUESTIONNAIRE; VIRUS HEPATITIS;

EID: 33745488448     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(06)73311-5     Document Type: Article

References (21)

1. Rumack BH. Acetaminophen misconceptions. Hepatology 2004;40:10-5.
2. Kaplowitz N. Acetaminophen Hepatoxicity: What Do We Know, What Don't We Know, and What Do We Do Next? Hepatology 2004;40:23-6.
3. Mofredj A, Cadranel JF, Darchy B, Barbare JC, Cazier A, Pras V, et al. Hepatotoxicity caused by therapeutic doses of paracetamol in alcoholics. Report of 2 cases of fatal hepatitis in cirrhosis. Ann Med Interne, Paris 1999;150:507-11.
4. Andreu V, Gomez-Angelats E, Bruguera M, Rodes J. Severe hepatitis from therapeutic doses of paracetamol in an alcoholic patient. Gastroenterol Hepatol 1999;22:235-7.
5. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics: a therapeutic misadventure. Ann Intern Med 1986;104:399-404.
6. Schmidt LE, Dalhoff K, Poulsen HE. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology 2002;35:876-82.
7. Prandota J Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye's syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons. Am J Ther 2002;9:149-56.
8. Jorup-Ronstrom C, Beermann B, Wahlin-Boll E, Melander A, Britton S. Reduction of acetaminophen and aspirin metabolism during viral hepatitis. Clin Pharmacokinet 1986;11:250-6.
9. Zapater P, Lasso De La Vega MC, Horga JF, Such J, Frances R, Esteban A, et al. Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status. Aliment Pharmacol Ther 2004;20:29-36.
10. Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003;38:613-18.
11. Polson J, Ocama P, Larson AM, Hynan L, Lalani E, Harrison M, et al. Role of acetaminophen in acute liver failure due to viral hepatitis (abstract). Hepatology 2003;34:544A.
12. Lee W. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the Risks of Hepatic Failure. Hepatology 2004;40:6-9.
13. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986;6:97-106.
14. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol 2002;40:3-20.
15. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994;272:1845-50.
16. Sklar GE, Subramaniam M. Acetylcysteine treatment for non-acetaminophen-induced acute liver failure. Ann Pharmacother 2004;38:498-500.
17. Schmidt LE, Knudsen TT, Dalhoff K, Bendtsen F. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury. Lancet 2002;360:1151-2.
18. Whyte IM, Buckley NA, Reith DM, Goodhew I, Seldon M, Dawson AH. Acetaminophen causes an increased International Normalized Ratio by reducing functional factor VII. Ther Drug Monit 2000;22:742-8.
19. Muldrew KL, James LP, Coop L, McCullough SS, Hendrickson HP, Hinson JA, et al. Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos 2002;30:446-51.
20. Davern TJ, James L, Larson A, Fontana R, Poison J, Lalani E, et al. Serum acetaminophen adducts identify patients with severe acetaminophen toxicity (abstract). Hepatology 2003;34:539A.
21. Bertholf RL, Johannsen LM, Bazooband A, Mansouri V. False-positive acetaminophen results in a hyperbilirubinemic patient. Clin Chem 2003;49:695-8.